UBS Group
ULBI icon

UBS Group’s Ultralife ULBI Stock Holding History

UBS Group’s Portfolio ULBI Stock Details ULBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$82.7K Buy
12,686
+8,103
+177% +$50.4K ﹤0.01% 7087
2025
Q4 		$26.2K Buy
4,583
+11
+0.2% +$68 ﹤0.01% 7603
2025
Q3 		$31.2K Sell
4,572
-2,650
-37% -$20.1K ﹤0.01% 7873
2025
Q2 		$64.9K Sell
7,222
-33,212
-82% -$197K ﹤0.01% 7567
2025
Q1 		$218K Sell
40,434
-56,935
-58% -$387K ﹤0.01% 6494
2024
Q4 		$725K Buy
97,369
+62,807
+182% +$516K ﹤0.01% 5579
2024
Q3 		$312K Sell
34,562
-4,863
-12% -$50.2K ﹤0.01% 5544
2024
Q2 		$419K Buy
39,425
+36,132
+1,097% +$385K ﹤0.01% 5138
2024
Q1 		$29K Sell
3,293
-1,390
-30% -$11.3K ﹤0.01% 6756
2023
Q4 		$31.9K Buy
4,683
+4,586
+4,728% +$37.6K ﹤0.01% 6810
2023
Q3 		$947 Sell
97
-2,109
-96% -$16.9K ﹤0.01% 8210
2023
Q2 		$10.7K Buy
2,206
+2,109
+2,174% +$9.17K ﹤0.01% 7127
2023
Q1 		$390 Hold
97
– – ﹤0.01% 9051
2022
Q4 		$374 Hold
97
– – ﹤0.01% 10217
2022
Q3 		$0 Hold
97
– – ﹤0.01% 10949
2022
Q2 		$0 Sell
97
-2,106
-96% -$10.4K ﹤0.01% 10969
2022
Q1 		$12K Buy
2,203
+2,106
+2,171% +$11.3K ﹤0.01% 8202
2021
Q4 		$1K Sell
97
-1,603
-94% -$9.84K ﹤0.01% 10041
2021
Q3 		$12K Buy
1,700
+704
+71% +$5.67K ﹤0.01% 7790
2021
Q2 		$8K Sell
996
-2,072
-68% -$17.8K ﹤0.01% 8257
2021
Q1 		$25K Buy
3,068
+173
+6% +$1.23K ﹤0.01% 7181
2020
Q4 		$19K Sell
2,895
-638
-18% -$4.03K ﹤0.01% 6993
2020
Q3 		$21K Buy
3,533
+314
+10% +$2.06K ﹤0.01% 6284
2020
Q2 		$23K Buy
3,219
+2,663
+479% +$19.5K ﹤0.01% 6472
2020
Q1 		$3K Sell
556
-255
-31% -$1.74K ﹤0.01% 7525
2019
Q4 		$6K Buy
811
+796
+5,307% +$6.6K ﹤0.01% 7533
2019
Q3 		$0 Sell
15
-1,396
-99% -$11.9K ﹤0.01% 8265
2019
Q2 		$11K Buy
+1,411
New +$12.8K ﹤0.01% 7031
2018
Q4 		– Sell
-1,047
Closed -$9K – 8307
2018
Q3 		$9K Buy
+1,047
New +$9.79K ﹤0.01% 7220
2018
Q2 		– Sell
-4,807
Closed -$48K – 8261
2018
Q1 		$48K Buy
+4,807
New +$37.2K ﹤0.01% 5745
2017
Q4 		– Sell
-4,311
Closed -$29K – 8111
2017
Q3 		$29K Buy
4,311
+1,311
+44% +$8.93K ﹤0.01% 6189
2017
Q2 		$22K Buy
+3,000
New +$18.4K ﹤0.01% 6231
2017
Q1 		– Sell
-2,068
Closed -$10K – 7989
2016
Q4 		$10K Sell
2,068
-7,128
-78% -$32K ﹤0.01% 6928
2016
Q3 		$38K Buy
9,196
+258
+3% +$1.13K ﹤0.01% 5736
2016
Q2 		$45K Buy
8,938
+5,946
+199% +$28.2K ﹤0.01% 5601
2016
Q1 		$15K Sell
2,992
-4,418
-60% -$23.9K ﹤0.01% 6407
2015
Q4 		$48K Buy
7,410
+6,610
+826% +$43.6K ﹤0.01% 5858
2015
Q3 		$5K Sell
800
-2,595
-76% -$11.6K ﹤0.01% 7730
2015
Q2 		$14K Buy
3,395
+2,595
+324% +$10.5K ﹤0.01% 7197
2015
Q1 		$3K Sell
800
-1,268
-61% -$4.38K ﹤0.01% 8344
2014
Q4 		$7K Buy
+2,068
New +$6.35K ﹤0.01% 8725

Other funds holding ULBI

VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
THC
Truffle Hound Capital Bethesda, Maryland $386M AUM 57.88% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

UBS Group's ULBI Position: Q1 2026 in Review

UBS Group increased its Ultralife (ULBI) stake by 177% in Q1 2026, buying an estimated $50.4K and bringing the position to 12,686 shares worth $82.7K. The position accounts for ﹤0.01% of the portfolio, ranked #7087.

UBS Group first reported a position in ULBI in Q4 2014 and has held it in 41 quarters since. The position peaked at $725K in Q4 2024. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.

  • UBS Group held 12,686 shares of Ultralife worth $82.7K as of Q1 2026.
  • UBS Group bought 8,103 Ultralife shares in Q1 2026, an estimated $50.4K.
  • Ultralife made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7087 holding.
  • UBS Group first reported a position in Ultralife in Q4 2014 and has held it in 41 quarters since.
  • UBS Group's Ultralife position peaked at $725K in Q4 2024.
  • 50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.